Protagonist Therapeutics (PTGX) Prepaid Assets (2015 - 2026)
Protagonist Therapeutics' (PTGX) quarterly Prepaid Assets came in at $1.1 million in Q1 2026, up 2.15% year-on-year from $1.1 million in Q1 2025, and down 89.16% quarter-over-quarter from $10.1 million in Q4 2025.
Protagonist Therapeutics (PTGX) Prepaid Assets (2015 - 2026) Analysis & Trends
Protagonist Therapeutics has disclosed Prepaid Assets across 12 years of filings, most recently posting $1.1 million for Q1 2026.
- Prepaid Assets for Q1 2026 came in at $1.1 million, up 2.15% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 million (up 2.15% YoY), and the FY2025 annual result was $10.1 million, up 1454.55% from the prior year.
- Prepaid Assets came in at $1.1 million for Q1 2026 at Protagonist Therapeutics, down from $10.1 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $10.1 million in Q4 2025 to a low of $582000.0 in Q2 2025.
- The 5-year median for Prepaid Assets is $1.1 million (2026), against an average of $2.0 million.
- Across the five-year window, Prepaid Assets plunged 88.6% in 2022 and jumped 1454.55% in 2025, its largest moves.
- Protagonist Therapeutics' Prepaid Assets stood at $1.4 million in 2022, then slipped by 0.49% to $1.4 million in 2023, then sank by 53.97% to $649000.0 in 2024, then surged by 1454.55% to $10.1 million in 2025, then plunged by 89.16% to $1.1 million in 2026.
- The last three Prepaid Assets figures came in at $1.1 million (Q1 2026), $10.1 million (Q4 2025), and $742000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Protagonist Therapeutics | 7.35 Bn | 7.35 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.09 Mn |
| Dec 31, 2025 | 10.09 Mn |
| Sep 30, 2025 | 742,000.00 |
| Jun 30, 2025 | 582,000.00 |
| Mar 31, 2025 | 1.07 Mn |
| Dec 31, 2024 | 649,000.00 |
| Sep 30, 2024 | 788,000.00 |
| Jun 30, 2024 | 1.08 Mn |
| Mar 31, 2024 | 4.88 Mn |
| Dec 31, 2023 | 1.41 Mn |
| Sep 30, 2023 | 1.21 Mn |
| Jun 30, 2023 | 827,000.00 |
| Mar 31, 2023 | 4.93 Mn |
| Dec 31, 2022 | 1.42 Mn |
| Sep 30, 2022 | 1.63 Mn |
| Jun 30, 2022 | 876,000.00 |
| Mar 31, 2022 | 1.43 Mn |
| Dec 31, 2021 | 1.75 Mn |
| Sep 30, 2021 | 8.88 Mn |
| Jun 30, 2021 | 7.68 Mn |